111 Capital Reduces Stock Holdings in Bath & Body Works, Inc. $BBWI

Key Points

• 111 Capital significantly reduced its holdings in Bath & Body Works, Inc. by 73.7% in the second quarter, now owning 7,905 shares valued at $237,000.
• The company announced a quarterly dividend of $0.20, with a dividend yield of 3.0%, reflecting a payout ratio of 23.74%.
• Analysts have varying ratings for Bath & Body Works, with an average target price of $38.15 and a consensus rating of "Moderate Buy."

111 Capital lessened its position in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 73.7% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 7,905 shares of the company's stock after selling 22,168 shares during the quarter. 111 Capital's holdings in Bath & Body Works were worth $237,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the business. SVB Wealth LLC purchased a new stake in shares of Bath & Body Works in the first quarter valued at about $35,000. Geneos Wealth Management Inc. raised its position in shares of Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company's stock worth $35,000 after purchasing an additional 801 shares during the last quarter. Parallel Advisors LLC lifted its stake in Bath & Body Works by 63.3% in the 2nd quarter. Parallel Advisors LLC now owns 1,241 shares of the company's stock valued at $37,000 after buying an additional 481 shares in the last quarter. Golden State Wealth Management LLC grew its holdings in Bath & Body Works by 94.7% during the 1st quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company's stock valued at $40,000 after buying an additional 642 shares during the last quarter. Finally, UMB Bank n.a. increased its position in Bath & Body Works by 65.9% during the first quarter. UMB Bank n.a. now owns 1,501 shares of the company's stock worth $46,000 after buying an additional 596 shares in the last quarter. 95.14% of the stock is currently owned by hedge funds and other institutional investors.

Bath & Body Works Price Performance

Shares of BBWI stock opened at $26.42 on Tuesday. The firm's 50-day simple moving average is $28.33 and its 200-day simple moving average is $29.43. Bath & Body Works, Inc. has a 1-year low of $24.93 and a 1-year high of $41.87. The firm has a market cap of $5.45 billion, a P/E ratio of 7.84, a PEG ratio of 0.88 and a beta of 1.52.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings results on Thursday, August 28th. The company reported $0.37 EPS for the quarter, hitting the consensus estimate of $0.37. The firm had revenue of $1.55 billion during the quarter, compared to analyst estimates of $1.55 billion. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. Bath & Body Works's revenue for the quarter was down .8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.37 earnings per share. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. Analysts expect that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, September 5th. Investors of record on Friday, August 22nd were given a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 3.0%. The ex-dividend date of this dividend was Friday, August 22nd. Bath & Body Works's dividend payout ratio (DPR) is 23.74%.

Analysts Set New Price Targets

Several brokerages have recently issued reports on BBWI. JPMorgan Chase & Co. restated a "neutral" rating and issued a $26.00 price objective on shares of Bath & Body Works in a research report on Monday. Barclays upped their target price on shares of Bath & Body Works from $30.00 to $32.00 and gave the company an "equal weight" rating in a report on Friday, August 29th. Telsey Advisory Group reiterated an "outperform" rating and set a $38.00 price target on shares of Bath & Body Works in a report on Thursday, August 28th. Wall Street Zen lowered shares of Bath & Body Works from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. Finally, Weiss Ratings restated a "hold (c-)" rating on shares of Bath & Body Works in a research report on Saturday, September 27th. Eleven equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $38.15.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.